[1]

Alatab S, Sepanlou SG, Ikuta K, Vahedi H, Bisignano C, et al. 2019. The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990–2017: a systematic analysis for the global burden of disease study 2017. The Lancet Gastroenterology & Hepatology 5:17−30

doi: 10.1016/S2468-1253(19)30333-4
[2]

Ott C, Schölmerich J. 2013. Extraintestinal manifestations and complications in IBD. Nature Reviews Gastroenterology & Hepatology 10:585−595

doi: 10.1038/nrgastro.2013.117
[3]

Argollo M, Gilardi D, Peyrin-Biroulet C, Chabot JF, Peyrin-Biroulet L, et al. 2019. Comorbidities in inflammatory bowel disease: a call for action. The Lancet Gastroenterology & Hepatology 4:643−654

doi: 10.1016/S2468-1253(19)30173-6
[4]

Hedin CRH, Vavricka SR, Stagg AJ, Schoepfer A, Raine T, et al. 2019. The pathogenesis of extraintestinal manifestations: implications for IBD research, diagnosis, and therapy. Journal of Crohn's & Colitis 13:541−554

doi: 10.1093/ecco-jcc/jjy191
[5]

Yilmaz S, Aydemir E, Maden A, Unsal B. 2007. The prevalence of ocular involvement in patients with inflammatory bowel disease. International Journal of Colorectal Disease 22:1027−1030

doi: 10.1007/s00384-007-0275-1
[6]

Pytrus W, Akutko K, Pytrus T, Turno-Kręcicka A. 2022. A review of ophthalmic complications in inflammatory bowel diseases. Journal of Clinical Medicine 11:7457

doi: 10.3390/jcm11247457
[7]

Zheng W, Su M, Hong N, Ye P. 2025. Gut-eye axis. Advances in Ophthalmology Practice and Research 5:165−174

doi: 10.1016/j.aopr.2025.01.003
[8]

Zhou L, Ma Y, Li X, Cao G. 2025. Gut-eye axis in ophthalmic diseases: focus on ocular neurodegeneration. Biomedicine & Pharmacotherapy 193:118800

doi: 10.1016/j.biopha.2025.118800
[9]

Napolitano P, Filippelli M, Davinelli S, Bartollino S, dell'Omo R, et al. 2021. Influence of gut microbiota on eye diseases: an overview. Annals of Medicine 53:750−761

doi: 10.1080/07853890.2021.1925150
[10]

Agrawal K, Hong ASY, Cifuentes-González C, Kumar VS, Rojas-Carabali W, et al. 2025. Microbiome signatures and their role in uveitis: pathogenesis, diagnostics, and therapeutic perspectives. Progress in Retinal and Eye Research 109:101409

doi: 10.1016/j.preteyeres.2025.101409
[11]

Lima-Fontes M, Meira L, Barata P, Falcão M, Carneiro Â. 2022. Gut microbiota and age-related macular degeneration: a growing partnership. Survey of Ophthalmology 67:883−891

doi: 10.1016/j.survophthal.2021.11.009
[12]

Granstam E, Rönnblom A. 2023. Occurrence of uveitis in a population-based cohort of inflammatory bowel diseases followed for 10 years: an observational study. BMJ Open Ophthalmology 8:e001318

doi: 10.1136/bmjophth-2023-001318
[13]

Ben-Tov A, Achler T, Patalon T, Gazit S, Yanai H, et al. 2025. The prevalence and characteristics of inflammatory bowel disease-related ocular involvement in children. Inflammatory Bowel Diseases 31:1256−1262

doi: 10.1093/ibd/izae160
[14]

Ren SJ, Liu T, Xu MH, Shi W, Li XR. 2024. Inflammatory bowel disease and risk of ophthalmic inflammation-related diseases: a two-sample Mendelian randomization study. International Journal of Ophthalmology 17:2100−2108

doi: 10.18240/ijo.2024.11.17
[15]

Luo L, Tang X, Xu J, Bao Y, Hu X, et al. 2025. The causal effects of inflammatory bowel disease on its ocular manifestations: a Mendelian randomization study. PLoS One 20:e0316437

doi: 10.1371/journal.pone.0316437
[16]

Xue Z, Yuan J, Chen F, Yao Y, Xing S, et al. 2022. Genome-wide association meta-analysis of 88, 250 individuals highlights pleiotropic mechanisms of five ocular diseases in UK biobank. eBioMedicine 82:104161

doi: 10.1016/j.ebiom.2022.104161
[17]

de Lange KM, Moutsianas L, Lee JC, Lamb CA, Luo Y, et al. 2017. Genome-wide association study implicates immune activation of multiple integrin genes in inflammatory bowel disease. Nature Genetics 49:256−261

doi: 10.1038/ng.3760
[18]

Sudlow C, Gallacher J, Allen N, Beral V, Burton P, et al. 2015. UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Medicine 12:e1001779

doi: 10.1371/journal.pmed.1001779
[19]

Lloyd-Jones DM, Hong Y, Labarthe D, Mozaffarian D, Appel LJ, et al. 2010. Defining and setting national goals for cardiovascular health promotion and disease reduction: the American heart association's strategic impact goal through 2020 and beyond. Circulation 121:586−613

doi: 10.1161/CIRCULATIONAHA.109.192703
[20]

Chen J, Dan L, Sun Y, Yuan S, Liu W, et al. 2023. Ambient air pollution and risk of enterotomy, gastrointestinal cancer, and all-cause mortality among 4, 708 individuals with inflammatory bowel disease: a prospective cohort study. Environmental Health Perspectives 131:77010

doi: 10.1289/EHP12215
[21]

Liu JZ, van Sommeren S, Huang H, Ng SC, Alberts R, et al. 2015. Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations. Nature Genetics 47:979−986

doi: 10.1038/ng.3359
[22]

Verma A, Huffman JE, Rodriguez A, Conery M, Liu M, et al. 2024. Diversity and scale: genetic architecture of 2068 traits in the VA million veteran program. Science 385:eadj1182

doi: 10.1126/science.adj1182
[23]

Grambsch PM, Therneau TM. 1994. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika 81:515−526

doi: 10.1093/biomet/81.3.515
[24]

Bulik-Sullivan B, Finucane HK, Anttila V, Gusev A, Day FR, et al. 2015. An atlas of genetic correlations across human diseases and traits. Nature Genetics 47:1236−1241

doi: 10.1038/ng.3406
[25]

Shi H, Mancuso N, Spendlove S, Pasaniuc B. 2017. Local genetic correlation gives insights into the shared genetic architecture of complex traits. American Journal of Human Genetics 101:737−751

doi: 10.1016/j.ajhg.2017.09.022
[26]

Turley P, Walters RK, Maghzian O, Okbay A, Lee JJ, et al. 2018. Multi-trait analysis of genome-wide association summary statistics using MTAG. Nature Genetics 50:229−237

doi: 10.1038/s41588-017-0009-4
[27]

Li X, Zhu X. 2017. Cross-phenotype association analysis using summary statistics from GWAS. In Statistical Human Genetics, ed. Elston RC. New York, NY: Humana. pp.455−467 doi: 10.1007/978-1-4939-7274-6_22
[28]

Yang Y, Musco H, Simpson-Yap S, Zhu Z, Wang Y, et al. 2021. Investigating the shared genetic architecture between multiple sclerosis and inflammatory bowel diseases. Nature Communications 12:5641

doi: 10.1038/s41467-021-25768-0
[29]

Wu T, Hu E, Xu S, Chen M, Guo P, et al. 2021. clusterProfiler 4.0: a universal enrichment tool for interpreting omics data. The Innovation 2:100141

doi: 10.1016/j.xinn.2021.100141
[30]

Giambartolomei C, Vukcevic D, Schadt EE, Franke L, Hingorani AD, et al. 2014. Bayesian test for colocalisation between pairs of genetic association studies using summary statistics. PLoS Genetics 10:e1004383

doi: 10.1371/journal.pgen.1004383
[31]

Zhu Z, Zheng Z, Zhang F, Wu Y, Trzaskowski M, et al. 2018. Causal associations between risk factors and common diseases inferred from GWAS summary data. Nature Communications 9:224

doi: 10.1038/s41467-017-02317-2
[32]

Lorincz-Comi N, Yang Y, Li G, Zhu X. 2024. MRBEE: a bias-corrected multivariable Mendelian randomization method. HGG Advances 5:100290

doi: 10.1016/j.xhgg.2024.100290
[33]

Verbanck M, Chen CY, Neale B, Do R. 2018. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nature Genetics 50:693−698

doi: 10.1038/s41588-018-0099-7
[34]

O'Brien CL, Summers KM, Martin NM, Carter-Cusack D, Yang Y, et al. 2024. The relationship between extreme inter-individual variation in macrophage gene expression and genetic susceptibility to inflammatory bowel disease. Human Genetics 143:233−261

doi: 10.1007/s00439-024-02642-9
[35]

Bordbar A, Manches O, Nowatzky J. 2024. Biology of HLA class I associated inflammatory diseases. Best Practice & Research Clinical Rheumatology 38:101977

doi: 10.1016/j.berh.2024.101977
[36]

Kulski JK. 2019. Long noncoding RNA HCP5, a hybrid HLA class I endogenous retroviral gene: structure, expression, and disease associations. Cells 8:480

doi: 10.3390/cells8050480
[37]

Jin Y, Lu HM, Yu XH. 2026. Pleiotropic gene mapping reveals shared immune regulatory hubs across 15 autoimmune diseases. Human Immunology 87:111636

doi: 10.1016/j.humimm.2025.111636
[38]

Han D, Liu G, Oh Y, Oh S, Yang S, et al. 2023. ZBTB12 is a molecular barrier to dedifferentiation in human pluripotent stem cells. Nature Communications 14:632

doi: 10.1038/s41467-023-36178-9
[39]

Ma H, Hu T, Tao W, Tong J, Han Z, et al. 2023. A lncRNA from an inflammatory bowel disease risk locus maintains intestinal host-commensal homeostasis. Cell Research 33:372−388

doi: 10.1038/s41422-023-00790-7
[40]

Johnson JL, Sargsyan D, Neiman EM, Hart A, Stojmirovic A, et al. 2024. Gene coexpression networks reveal a broad role for lncRNAs in inflammatory bowel disease. JCI Insight 9:e168988

doi: 10.1172/jci.insight.168988
[41]

Halling ML, Kjeldsen J, Knudsen T, Nielsen J, Hansen LK. 2017. Patients with inflammatory bowel disease have increased risk of autoimmune and inflammatory diseases. World Journal of Gastroenterology 23:6137−6146

doi: 10.3748/wjg.v23.i33.6137
[42]

Chan HN, Zhang XJ, Ling XT, Bui CHT, Wang YM, et al. 2022. Vitamin D and ocular diseases: a systematic review. International Journal of Molecular Sciences 23:4226

doi: 10.3390/ijms23084226
[43]

Wang SY, Singh K, Lin SC. 2012. The association between glaucoma prevalence and supplementation with the oxidants calcium and iron. Investigative Ophthalmology & Visual Science 53:725−731

doi: 10.1167/iovs.12-10315
[44]

He Y, Ge J, Tombran-Tink J. 2008. Mitochondrial defects and dysfunction in calcium regulation in glaucomatous trabecular meshwork cells. Investigative Ophthalmology & Visual Science 49:4912−4922

doi: 10.1167/iovs.08-2192
[45]

Shiga Y, Rangel Olguin AG, El Hajji S, Belforte N, Quintero H, et al. 2024. Endoplasmic reticulum stress-related deficits in calcium clearance promote neuronal dysfunction that is prevented by SERCA2 gene augmentation. Cell Reports Medicine 5:101839

doi: 10.1016/j.xcrm.2024.101839
[46]

Saez A, Herrero-Fernandez B, Gomez-Bris R, Sánchez-Martinez H, Gonzalez-Granado JM. 2023. Pathophysiology of inflammatory bowel disease: innate immune system. International Journal of Molecular Sciences 24:1526

doi: 10.3390/ijms24021526
[47]

Woo SJ, Ahn SJ, Ahn J, Park KH, Lee K. 2011. Elevated systemic neutrophil count in diabetic retinopathy and diabetes: a hospital-based cross-sectional study of 30, 793 Korean subjects. Investigative Ophthalmology & Visual Science 52:7697−7703

doi: 10.1167/iovs.11-7784
[48]

Liu H, Lessieur EM, Saadane A, Lindstrom SI, Taylor PR, et al. 2019. Neutrophil elastase contributes to the pathological vascular permeability characteristic of diabetic retinopathy. Diabetologia 62:2365−2374

doi: 10.1007/s00125-019-04998-4
[49]

Wang L, Zhou X, Yin Y, Mai Y, Wang D, et al. 2019. Hyperglycemia induces neutrophil extracellular traps formation through an NADPH oxidase-dependent pathway in diabetic retinopathy. Frontiers in Immunology 9:3076

doi: 10.3389/fimmu.2018.03076
[50]

Deliyanti D, Suphapimol V, Ang P, Tang X, Jayasimhan A, et al. 2023. Early depletion of neutrophils reduces retinal inflammation and neovascularization in mice with oxygen-induced retinopathy. International Journal of Molecular Sciences 24:15680

doi: 10.3390/ijms242115680
[51]

Maghsoudlou P, Epps SJ, Guly CM, Dick AD. 2025. Uveitis in adults: a review. JAMA 334:419−434

doi: 10.1001/jama.2025.4358
[52]

Saez A, Gomez-Bris R, Herrero-Fernandez B, Mingorance C, Rius C, et al. 2021. Innate lymphoid cells in intestinal homeostasis and inflammatory bowel disease. International Journal of Molecular Sciences 22:7618

doi: 10.3390/ijms22147618
[53]

Nakamura YK, Janowitz C, Metea C, Asquith M, Karstens L, et al. 2017. Short chain fatty acids ameliorate immune-mediated uveitis partially by altering migration of lymphocytes from the intestine. Scientific Reports 7:11745

doi: 10.1038/s41598-017-12163-3
[54]

He C, Xiu W, Chen Q, Peng K, Zhu X, et al. 2023. Gut-licensed β7+ CD4+ T cells contribute to progressive retinal ganglion cell damage in glaucoma. Science Translational Medicine 15:eadg1656

doi: 10.1126/scitranslmed.adg1656
[55]

Yeşil A, Şenateş E, Bayoğlu İV, Erdem ED, Demirtunç R, et al. 2011. Red cell distribution width: a novel marker of activity in inflammatory bowel disease. Gut and Liver 5:460−467

doi: 10.5009/gnl.2011.5.4.460
[56]

Vashistha T, Streja E, Molnar MZ, Rhee CM, Moradi H, et al. 2016. Red cell distribution width and mortality in hemodialysis patients. American Journal of Kidney Diseases 68:110−121

doi: 10.1053/j.ajkd.2015.11.020
[57]

Migliorisi G, Vella G, Dal Buono A, Gabbiadini R, Busacca A, et al. 2024. Ophthalmological manifestations in inflammatory bowel diseases: keep an eye on it. Cells 13:142

doi: 10.3390/cells13020142
[58]

Lo TC, Chen YY, Chen HH. 2022. Risk of inflammatory bowel disease in uveitis patients: a population-based cohort study. Eye 36:1288−1293

doi: 10.1038/s41433-021-01645-4
[59]

Amadi-Obi A, Yu CR, Liu X, Mahdi RM, Clarke GL, et al. 2007. TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1. Nature Medicine 13:711−718

doi: 10.1038/nm1585
[60]

Jiang P, Zheng C, Xiang Y, Malik S, Su D, et al. 2023. The involvement of TH17 cells in the pathogenesis of IBD. Cytokine & Growth Factor Reviews 69:28−42

doi: 10.1016/j.cytogfr.2022.07.005
[61]

Liu Y, Lear T, Zhao Y, Zhao J, Zou C, et al. 2015. F-box protein Fbxl18 mediates polyubiquitylation and proteasomal degradation of the pro-apoptotic SCF subunit Fbxl7. Cell Death & Disease 6:e1630

doi: 10.1038/cddis.2014.585
[62]

Rossi S, Gesualdo C, Maisto R, Trotta MC, Di Carluccio N, et al. 2017. High levels of serum ubiquitin and proteasome in a case of HLA-B27 uveitis. International Journal of Molecular Sciences 18:505

doi: 10.3390/ijms18030505
[63]

Rahimov F, Ghosh S, Petiwala S, Schmidt M, Nyamugenda E, et al. 2025. A genome-wide CRISPR screen identifies the TNRC18 gene locus as a regulator of inflammatory signaling. Nature Communications 16:10346

doi: 10.1038/s41467-025-65277-y
[64]

Zhao R, Zhou H, Su SB. 2013. A critical role for interleukin-1β in the progression of autoimmune diseases. International Immunopharmacology 17:658−669

doi: 10.1016/j.intimp.2013.08.012
[65]

Duerr RH, Taylor KD, Brant SR, Rioux JD, Silverberg MS, et al. 2006. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 314:1461−1463

doi: 10.3410/f.1047044.506565
[66]

Zhong Z, Su G, Kijlstra A, Yang P. 2021. Activation of the interleukin-23/interleukin-17 signalling pathway in autoinflammatory and autoimmune uveitis. Progress in Retinal and Eye Research 80:100866

doi: 10.1016/j.preteyeres.2020.100866
[67]

Feagan BG, Sandborn WJ, Gasink C, Jacobstein D, Lang Y, et al. 2016. Ustekinumab as induction and maintenance therapy for Crohn's disease. New England Journal of Medicine 375:1946−1960

doi: 10.1056/NEJMoa1602773